CRISPR/Cas9 nickase-mediated inactivation of hepatitis B virus replication

被引：0
|
作者：
Karimova, M. [1 ]
Beschorner, N. [1 ]
Dammermann, W. [2 ]
Chemnitz, J. [1 ]
Indenbirken, D. [1 ]
Grundhoff, A. [1 ,3 ]
Lueth, S. [2 ]
Buchholz, F. [4 ,5 ]
zur Wiesch, J. Schulze [6 ]
Hauber, J. [1 ]
机构：
[1] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf 1, Inst Expt Immunol & Hepatol, Dept Med, Hamburg, Germany
[3] German Ctr Infect Res DZIF, Hamburg, Germany
[4] Univ Hosp, Dept Med Syst Biol, Dresden, Germany
[5] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany
[6] Univ Med Ctr Hamburg Eppendorf 1, Dept Med, Hamburg, Germany
来源：
JOURNAL OF VIRAL HEPATITIS | 2015年 / 22卷
关键词：
D O I：
10.1111/jvh.23_12425
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P025
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [1] CRISPR/Cas9 "double"-nickase mediated inactivation of hepatitis B virus replication
    Karimova, Madina
    Beschorner, Niklas
    Dammermann, Werner
    Chemnitz, Jan
    Indenbirken, Daniela S.
    Grundhoff, Adam
    Lueth, Stefan
    Buchholz, Frank
    Julian, Schulze zur Wiesch
    Hauber, Joachim
    HEPATOLOGY, 2015, 62 : 1003A - 1003A
  • [2] CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
    Karimova, Madina
    Beschorner, Niklas
    Dammermann, Werner
    Chemnitz, Jan
    Indenbirken, Daniela
    Bockmann, Jan-Hendrik
    Grundhoff, Adam
    Lueth, Stefan
    Buchholz, Frank
    zur Wiesch, Julian Schulze
    Hauber, Joachim
    SCIENTIFIC REPORTS, 2015, 5
  • [3] CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
    Madina Karimova
    Niklas Beschorner
    Werner Dammermann
    Jan Chemnitz
    Daniela Indenbirken
    Jan-Hendrik Bockmann
    Adam Grundhoff
    Stefan Lüth
    Frank Buchholz
    Julian Schulze zur Wiesch
    Joachim Hauber
    Scientific Reports, 5
  • [4] Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA
    Andrés Felipe Leal
    Carlos Javier Alméciga-Díaz
    Gene Therapy, 2023, 30 : 107 - 114
  • [5] Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA
    Felipe Leal, Andres
    Javier Almeciga-Diaz, Carlos
    GENE THERAPY, 2023, 30 (1-2) : 107 - 114
  • [6] Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus
    Sakuma, Tetsushi
    Masaki, Keiichi
    Abe-Chayama, Hiromi
    Mochida, Keiji
    Yamamoto, Takashi
    Chayama, Kazuaki
    GENES TO CELLS, 2016, 21 (11) : 1253 - 1262
  • [7] Targeting Hepatitis B Virus With CRISPR/Cas9
    Seeger, Christoph
    Sohn, Ji A.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2014, 3 : e216
  • [8] CRISPR/Cas9 nickase-mediated efficient and seamless knock-in of lethal genes in the medaka fish Oryzias latipes
    Murakami, Yu
    Futamata, Ryota
    Horibe, Tomohisa
    Ueda, Kazumitsu
    Kinoshita, Masato
    DEVELOPMENT GROWTH & DIFFERENTIATION, 2020, 62 (09) : 554 - 567
  • [9] CRISPR/Cas9 for hepatitis B virus infection treatment
    Cai, Bo
    Chang, Shixue
    Tian, Yuhan
    Zhen, Shuai
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (05)
  • [10] Targeting hepatitis B virus with CRISPR/Cas9 approach
    Martinez, Maria Guadalupe
    Inchauspe, Aurore
    Delberghe, Elodie
    Chapus, Fleur
    Neveu, Gregory
    Alam, Antoine
    Carter, Kara
    Testoni, Barbara
    Zoulim, Fabien
    JOURNAL OF HEPATOLOGY, 2020, 73 : S841 - S842
12345